Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [18F]SiTATE: nuclear medicine
Somatostatin receptor positron emission tomography/computed tomography (SSTR-PET/CT) using [68Ga]-labeled tracers is a widely used imaging modality for neuroendocrine tumors (NET). Recently, [18F]SiTATE, a SiFAlin tagged [Tyr3]-octreotate (TATE) PET tracer, has shown great potential due to favorable...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
November 2024
|
| In: |
European radiology
Year: 2024, Volume: 34, Issue: 11, Pages: 7222-7232 |
| ISSN: | 1432-1084 |
| DOI: | 10.1007/s00330-024-10788-3 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00330-024-10788-3 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00330-024-10788-3#citeas |
| Author Notes: | R. Ebner, A. Lohse, M.P. Fabritius, J. Rübenthaler, C. Wängler, B. Wängler, R. Schirrmacher, F. Völter, H.P. Schmid, L.M. Unterrainer, O. Öcal, A. Hinterberger, C. Spitzweg, C.J. Auernhammer, T. Geyer, J. Ricke, P. Bartenstein, A. Holzgreve and F. Grawe |
| Summary: | Somatostatin receptor positron emission tomography/computed tomography (SSTR-PET/CT) using [68Ga]-labeled tracers is a widely used imaging modality for neuroendocrine tumors (NET). Recently, [18F]SiTATE, a SiFAlin tagged [Tyr3]-octreotate (TATE) PET tracer, has shown great potential due to favorable clinical characteristics. We aimed to evaluate the reproducibility of Somatostatin Receptor-Reporting and Data System 1.0 (SSTR-RADS 1.0) for structured interpretation and treatment planning of NET using [18F]SiTATE. |
|---|---|
| Item Description: | Online veröffentlicht: 20. Mai 2024 Im Titel steht "18F" in eckigen Klammern und die Zahl 18 ist hochgestellt Gesehen am 10.12.2024 |
| Physical Description: | Online Resource |
| ISSN: | 1432-1084 |
| DOI: | 10.1007/s00330-024-10788-3 |